Barclays’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $200M | Buy |
740,400
+126,700
| +21% | +$37.7M | 0.05% | 294 |
|
|
2025
Q4 | $203M | Buy |
613,700
+459,400
| +298% | +$156M | 0.05% | 283 |
|
|
2025
Q3 | $53.3M | Sell |
154,300
-111,400
| -42% | -$33.7M | 0.01% | 738 |
|
|
2025
Q2 | $82.9M | Buy |
+265,700
| New | +$102M | 0.02% | 537 |
|
|
2025
Q1 | – | Sell |
-54,600
| Closed | -$27.6M | – | 5572 |
|
|
2024
Q4 | $27.6M | Buy |
54,600
+15,100
| +38% | +$8.58M | 0.01% | 936 |
|
|
2024
Q3 | $23.1M | Buy |
+39,500
| New | +$22.3M | 0.01% | 992 |
|
|
2024
Q2 | – | Sell |
-9,100
| Closed | -$4.5M | – | 5312 |
|
|
2024
Q1 | $4.5M | Sell |
9,100
-166,400
| -95% | -$84.6M | ﹤0.01% | 1938 |
|
|
2023
Q4 | $92.4M | Buy |
+175,500
| New | +$93.6M | 0.03% | 440 |
|
|
2023
Q2 | – | Sell |
-130,800
| Closed | -$61.8M | – | 5094 |
|
|
2023
Q1 | $61.8M | Sell |
130,800
-51,000
| -28% | -$24.6M | 0.03% | 383 |
|
|
2022
Q4 | $96.4M | Buy |
+181,800
| New | +$96.3M | 0.04% | 282 |
|
|
2022
Q3 | – | Sell |
-126,200
| Closed | -$64.8M | – | 5153 |
|
|
2022
Q2 | $64.8M | Buy |
+126,200
| New | +$63.4M | 0.04% | 315 |
|
|
2022
Q1 | – | Sell |
-1,600
| Closed | -$803K | – | 5639 |
|
|
2021
Q4 | $803K | Hold |
1,600
| – | – | ﹤0.01% | 2962 |
|
|
2021
Q3 | $625K | Hold |
1,600
| – | – | ﹤0.01% | 3064 |
|
|
2021
Q2 | $641K | Hold |
1,600
| – | – | ﹤0.01% | 2930 |
|
|
2021
Q1 | $595K | Sell |
1,600
-318,400
| -100% | -$110M | ﹤0.01% | 3087 |
|
|
2020
Q4 | $112M | Buy |
320,000
+225,500
| +239% | +$75.6M | 0.06% | 245 |
|
|
2020
Q3 | $29.5M | Sell |
94,500
-5,700
| -6% | -$1.75M | 0.02% | 575 |
|
|
2020
Q2 | $29.6M | Sell |
100,200
-64,700
| -39% | -$18.5M | 0.02% | 489 |
|
|
2020
Q1 | $41.1M | Sell |
164,900
-112,700
| -41% | -$31M | 0.03% | 367 |
|
|
2019
Q4 | $81.6M | Buy |
277,600
+8,800
| +3% | +$2.3M | 0.05% | 320 |
|
|
2019
Q3 | $58.4M | Sell |
268,800
-122,000
| -31% | -$29.4M | 0.04% | 400 |
|
|
2019
Q2 | $95.4M | Buy |
390,800
+271,700
| +228% | +$65.3M | 0.06% | 281 |
|
|
2019
Q1 | $29.4M | Sell |
119,100
-106,500
| -47% | -$27.2M | 0.02% | 658 |
|
|
2018
Q4 | $56.2M | Buy |
225,600
+136,600
| +153% | +$36.1M | 0.04% | 342 |
|
|
2018
Q3 | $23.7M | Buy |
89,000
+12,700
| +17% | +$3.3M | 0.02% | 756 |
|
|
2018
Q2 | $18.7M | Sell |
76,300
-52,900
| -41% | -$12.7M | 0.02% | 821 |
|
|
2018
Q1 | $27.6M | Buy |
129,200
+56,200
| +77% | +$12.8M | 0.02% | 690 |
|
|
2017
Q4 | $16.1M | Buy |
73,000
+12,200
| +20% | +$2.59M | 0.01% | 924 |
|
|
2017
Q3 | $11.9M | Sell |
60,800
-9,000
| -13% | -$1.74M | 0.01% | 944 |
|
|
2017
Q2 | $12.9M | Sell |
69,800
-64,500
| -48% | -$11.3M | 0.01% | 829 |
|
|
2017
Q1 | $22M | Buy |
134,300
+1,900
| +1% | +$311K | 0.02% | 531 |
|
|
2016
Q4 | $21.2M | Sell |
132,400
-34,800
| -21% | -$5.2M | 0.02% | 569 |
|
|
2016
Q3 | $23.4M | Buy |
167,200
+38,800
| +30% | +$5.43M | 0.03% | 485 |
|
|
2016
Q2 | $18.1M | Sell |
128,400
-14,000
| -10% | -$1.87M | 0.02% | 558 |
|
|
2016
Q1 | $18.2M | Sell |
142,400
-138,600
| -49% | -$16.4M | 0.03% | 508 |
|
|
2015
Q4 | $32.9M | Buy |
281,000
+28,400
| +11% | +$3.32M | 0.04% | 391 |
|
|
2015
Q3 | $29.3M | Buy |
252,600
+39,300
| +18% | +$4.7M | 0.04% | 436 |
|
|
2015
Q2 | $26M | Buy |
213,300
+84,500
| +66% | +$10M | 0.03% | 526 |
|
|
2015
Q1 | $15.2M | Sell |
128,800
-230,400
| -64% | -$25.6M | 0.02% | 833 |
|
|
2014
Q4 | $36.3M | Sell |
359,200
-210,800
| -37% | -$20M | 0.03% | 476 |
|
|
2014
Q3 | $49M | Sell |
570,000
-7,700
| -1% | -$651K | 0.05% | 329 |
|
|
2014
Q2 | $46.8M | Buy |
577,700
+428,500
| +287% | +$33.7M | 0.05% | 337 |
|
|
2014
Q1 | $12.1M | Sell |
149,200
-35,900
| -19% | -$2.7M | 0.01% | 1009 |
|
|
2013
Q4 | $13.9M | Buy |
185,100
+54,600
| +42% | +$3.92M | 0.01% | 1011 |
|
|
2013
Q3 | $9.27M | Sell |
130,500
-7,000
| -5% | -$501K | 0.01% | 1201 |
|
|
2013
Q2 | $9M | Buy |
+137,500
| New | +$8.56M | 0.01% | 1150 |
|
Other funds holding UNH
VCM
VPM
Barclays's UNH Position: Q1 2026 in Review
Barclays reduced its UnitedHealth (UNH) stake by 14% in Q1 2026, selling an estimated $136M and leaving 2,817,725 shares worth $762M. The position accounts for 0.18% of the portfolio, ranked #79.
Barclays first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.23B in Q1 2025. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Barclays held 2,817,725 shares of UnitedHealth worth $762M as of Q1 2026.
- Barclays sold 456,917 UnitedHealth shares in Q1 2026, an estimated $136M.
- UnitedHealth made up 0.18% of Barclays's portfolio in Q1 2026, its #79 holding.
- Barclays first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
- Barclays's UnitedHealth position peaked at $2.23B in Q1 2025.
- 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.